首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 107 毫秒
1.
目的通过建立低氧性肺动脉高压大鼠模型,探讨增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)在大鼠低氧性肺血管平滑肌细胞中的表达。方法将SPF级SD大鼠随机分为正常对照组(n=10)、模型组(n=10),通过间断常压低氧法建立大鼠低氧性肺动脉高压模型,肺组织切片经HE染色后图像分析技术定量检测大鼠肺小动脉的形态改变;免疫组织化学染色法测定肺血管平滑肌细胞内PCNA蛋白表达,并经图像分析半定量检测其表达强度。结果 4周后,模型组SD大鼠MT%、MA%与对照组比较,差异具有显著性(P<0.05);模型组SD大鼠肺血管平滑肌细胞内PCNA核蛋白表达(积分面积、累积光密度)与对照组比较,差异具有显著性(P<0.05)。结论常压低氧4周可成功建立肺动脉高压大鼠模型,PCNA在肺血管平滑肌细胞中的表达量具有差异性提示其可能在肺动脉高压形成过程中起重要作用。  相似文献   

2.
李园园  陆长德 《生命科学》2003,15(3):143-146
增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)是一种生长调控蛋白,在DNA复制、修复、细胞周期调控、基因外遗传(epigenetic inheritance)等事件的协同机制中发挥重要功能。PCNA的表达调控发生在多个层次,涉及ATFl、CREB、RFXl、p53、E2F等转录因子以及内含子指导的反义RNA等等。  相似文献   

3.
将中和性流行性感冒 (流感 )病毒基因工程抗体IV 2、IV 6的轻链和重链Fd段基因 ,分别克隆入全抗体表达载体 pAC L Fc ,构建成杆状病毒表达载体pAC L Fc Ⅳ 2和 pAC L Fc Ⅳ 6 ,转染昆虫Sf9细胞 ,利用杆状病毒 /昆虫细胞系统实现抗体的分泌型表达 ,表达产物进行亲和层析分离纯化。SDS PAGE电泳和Westernblot法证实有完整免疫球蛋白的表达 ,免疫印迹法证实它们能与流感病毒血凝素蛋白特异性结合。经间接竞争性抑制ELISA法测定 ,抗体与流感病毒抗原结合的解离常数KD 值分别为 2 5× 10 -9M和 3 0× 10 -9M。流感病毒基因工程全抗体经在昆虫细胞中的表达、纯化和抗体特性鉴定 ,获得了两株纯化的全抗体 ,可用于以后的动物模型呼吸道粘膜被动免疫抗感染的研究。  相似文献   

4.
目的研究小鼠肾小体发生发育过程中增殖细胞核抗原(PCNA)的表达水平.方法采用免疫组织化学方法结合光学显微镜技术.结果比较发育不同阶段肾小体PCNA表达时,处于原始阶段,即Ⅰ期和Ⅱ期肾小体内PCNA阳性率最高;而随着肾小体生长发育和成熟,即Ⅲ、Ⅳ、Ⅴ期肾小体,PCNA的表达会逐渐减弱.在比较不同胚龄及生后日龄的同期肾小体时发现,Ⅰ期、Ⅱ期肾小体内PCNA阳性细胞率不因胚(日)龄的增加而变化;而Ⅲ期、Ⅳ期和Ⅴ期随着胚龄的增加,特别是生后日龄的增加阳性率逐渐下降.结论细胞增殖在肾小体发育的整个过程中是由高逐渐减低.生后龄肾内生长阶段肾小体的PCNA阳性率明显低于胚龄时生长阶段肾小体.  相似文献   

5.
用ribozyme抑制增殖细胞核抗原的表达对HeLa细胞增殖的影响   总被引:1,自引:0,他引:1  
增殖细胞核抗的(PCNA)是DNA聚合酶δ的辅助蛋白,它是细胞染色体DNA复制所必需的。人工设计的ribozyme具有可特异地切割PCNAmRNA的性质,将此ribozyme的自剪体内表达质粒导入HeLa细胞,从细胞决RNA中分离相应部分能在体外切割靶RNA片段,证明此表达质粒在细胞内能表达出有活性的ribozyme分子。与对照相比,导入ribozyme表达质粒的HeLa细胞进入S期的时间从12h  相似文献   

6.
SARS冠状病毒S蛋白在昆虫细胞中的表达和纯化   总被引:3,自引:0,他引:3  
导致严重急性呼吸综合征(sevcre acute rcspiratory syndrome,SARS)的元凶是一种新型的冠状病毒(SARS coronavirus,SARS-CoV)。SARS-CoV感染入侵宿主细胞关键的一环是病毒自身的棘突蛋白(spike protein,S-protein)与细胞受体的相互作用,故而S蛋白己成为SARS研究的主要热点。  相似文献   

7.
PLCζ是PLC家族的一种新型同工酶,在哺乳动物卵母细胞激活中起着极其重要的作用。近年来,体外大量表达和纯化有活性的PLCζ蛋白用于结构生物学研究一直未能获得成功。本研究首次在杆状病毒表达系统中表达和纯化重组人PLCζ蛋白,首先将人PLCζ基因克隆至pFastBac-HTA质粒构建重组载体,转化DH10Bac发生位点特异性转座,经抗性和蓝白斑筛选,获得重组穿梭质粒Bacmid-PLCζ;在脂质体介导下将穿梭质粒转染Sf9昆虫细胞产生重组病毒,扩增病毒感染Sf9昆虫细胞进行蛋白表达;利用Ni~(2+)亲和柱及分子筛来纯化蛋白,并通过考马斯亮蓝染色、Western blotting及飞行时间质谱对蛋白进行鉴定,并进行酶活性测定。结果显示重组蛋白在Sf9昆虫细胞感染杆状病毒后72 h达到峰值并以分泌形式表达在细胞培养基中,Ni~(2+)亲和柱及分子筛纯化后的重组蛋白经Western blotting及电离飞行时间质谱鉴定为PLCζ蛋白,酶活性可达326.8 U/mL。该实验结果为重组人PLCζ蛋白大规模生产和生物医学应用研究提供了可参考利用的技术。  相似文献   

8.
目的:利用昆虫细胞表达系统真核表达并纯化小电导钙激活钾离子通道蛋白1(KCNN1)。方法:以基因重组方法构建杆状病毒穿梭质粒reBacmid-KCNN1,将其转染至杆状病毒/Sf9细胞表达系统表达目的蛋白,并用Western印迹鉴定KCNN1的表达水平;用Ni-IDA-Sepharose CL-6B亲和层析柱纯化裂解细胞上清中的KCNN1,并用Western印迹鉴定纯化结果。结果:KCNN1在Sf9细胞中高效表达,通过亲和层析获得了纯化的KCNN1。结论:膜蛋白KCCN1在昆虫细胞Sf9中的表达与纯化,为深入研究其分子生物学功能提供了材料,也为全长膜蛋白的体外表达提供了一套可借鉴的实验方法。  相似文献   

9.
应用RT-PCR技术,从人黑色素瘤Bowes细胞株中扩增出人组织型纤溶酶原激活剂(tissue-typeplasminogenactivator,t-PA)cDNA。序列分析证实,与国外的报道完全一致。将含完整阅读框架的人t-PAcDNA克隆至昆虫细胞表达转移载体pBacPAK8中,获得重组质粒pBac-tPA。应用脂质体共转染法,将pBactPA和线性化杆状病毒BacPAK6DNA共转染Tn-5B-1昆虫细胞。经空斑筛选获得11株重组病毒。经PCR鉴定与生物活性测定,获得一株高效表达t-PA的重组病毒BactPA3。在含胎牛血清的培养基中,t-PA表达活性在感染(MOI≈10)后72h左右达到最高,为3.04×103IU/ml,即相当于1.8×104IU/106细胞;在无血清培养基中,t-PA最高表达水平相差不大,但时间为感染后132h左右。经SDS-PAGE纤维蛋白自显影分析,分子量为68kda左右。与从人黑色素瘤细胞培养液中提纯的天然t-PA相比,其受纤维蛋白原激活的特性、和纤维蛋白的亲和力及在血浆中的失活速率基本相同。表达的t-PA在血液循环中的半衰期为7min。  相似文献   

10.
陆爱权  雷树勇 《蛇志》2002,14(1):20-21
目的 为了探导增殖细胞抗原 ( PCNA)的表达在胃粘膜良恶性病变的诊断分级的意义 ,以及与核仁组区蛋白 ( Ag-NOR)之间的关系。 方法 对 5 4例良恶性病变进行 PCNA免疫组化和 Ag-NOR检测进行分析研究。 结果 我们发现正常胃粘膜 PCNA平均指数 1 6 .73± 5 .7;非典型增生轻度 2 0 .85±6 .2 1、中度 2 5 .74± 7.7、重度 35 .1 5± 9.1 ;腺癌 5 8.2 3± 1 8.1 2。Ag-NOR正常胃粘膜 3.2 1± 0 .5 6 ;非典型增生轻度 4 .91± 0 .75、中度 6 .1 7± 0 .6 9、重度 8.75± 0 .87;腺癌 1 0 .1 2± 1 .97。 结论 PCNA的表达随着病理级别增加而增加 ,与 Ag-NOR成正比关系、综合 PCNA的检测结果 ,对胃粘膜的增生程度的判断以及非典型增生与癌的鉴别诊断有一定的参考价值。  相似文献   

11.
12.
目的:探讨增殖细胞核抗原(PCNA)和P27蛋白(P27)在老年胃癌中表达及其临床意义。方法:采用免疫组织化学SP法检测58例老年胃癌组织中PCNA、P27蛋白表达情况,分析它们与老年胃癌临床生物学行为的关系。结果:PCNA在老年胃癌组中的阳性表达率明显高于对照组的阳性表达率,P27在老年胃癌组中的阳性表达率明显低于对照组的阳性表达率。PCNA蛋白阳性表达与老年胃癌是否有浆膜浸润、组织分化程度、淋巴结转移以及TNM分期密切相关(P〈0.01),而P27蛋白阳性表达与老年胃癌类型、是否有浆膜浸润、组织分化程度、淋巴结转移以及TNM分期密切相关(P〈0.01)。老年胃癌组织中PCNA、P27的表达呈负相关(r=-0.536,P〈0.05)。结论:P27表达下调、PCNA表达增强在老年胃癌的发生、发展过程中具有重要的作用,且两者具有相互作用。  相似文献   

13.
目的:对比研究下颌骨牵张成骨中不同牵张频率的作用下新骨组织中成骨细胞的增殖活性,从而筛选出最佳牵张频率。方法:选用16只3月龄的幼年山羊,随机分为4组,每组4只,第1组为对照组,分别对第2、3、4组动物右下颌骨行骨皮质切开术后进行牵张,第2组牵张频率为2次/天,第3组牵张频率为4次/天,第4组牵张频率为6次/天,于完成牵张后4周时分别处死动物,取牵张区新骨组织和对照组右下颌骨颏孔区骨组织行PCNA免疫组化染色并进行组间比较。结果:各牵张组牵张区新生骨组织中成骨细胞PCNA表达的阳性细胞数均显著高于对照组,6次/天牵张组和4次/天牵张组牵张区中成骨细胞PCNA表达的阳性细胞数显著高于2次/天牵张组,但6次/天牵张组和4次/天牵张组成骨细胞PCNA表达的阳性细胞数无显著性差异。结论:在下颌骨牵张成骨进程中,随着牵张频率的增加,牵张区成骨细胞的增殖能力提高,可能术后成骨效果更佳。  相似文献   

14.
An immunohistochemical assay for proliferating cell nuclear antigen (PCNA) identifies cells in all active phases of the cell cycle. In this study, PCNA methodology, which was developed primarily for mammalian tissues, was adapted to three small fish species, medaka (Ory-zias latipes), guppy (Poecilia reticulata), and western mosquitofish (Gambusia affiinis) that are used in carcinogenesis bioassays and environmental sentinel studies. Our study showed that PCNA can be identified in routinely processed, paraffin embedded specimens of these fishes. Optimum staining conditions were dependent on fixative, primary antibody, antigen retrieval processing. and protein blocking reagent. Best results were achieved using 10% neutral buffered formalin as the fixative, clone PC10 as the primary antibody, and a combination of powdered milk and bovine serum albumin as a protein block. Except for medaka specimens, antigen retrieval was not required for specimens preserved in 10% neutral buffered formalin. but was required for the other fixatives tested. In whole fish specimens, PCNA marked cells in normally proliferating tissues such as testis. ovary, primary filament epithelium of the gill, hematopoietic tissues, thymus, retina and alimentary tract. The study demonstrated the successful application of mammalian-based PCNA technology to these aquatic species. Further applications of the assay will aid in understanding the role of cell proliferation in normal, diseased, and toxicant-affected tissues of aquatic animals.  相似文献   

15.
细胞增殖核抗原(proliferating cell nuclear antigen,PCNA)基因是DNA聚合酶δ的辅助因子,在真核细胞DNA复制及其损伤修复中发挥着重要的作用.采用高效热不对称交互PCR法(high-efficiency thermal asymmetric interlaced PCR,hiTAIL PCR)从小麦西农1 376基因组中扩增得到小麦PCNA基因启动子片段,并命名为TaPCNA启动子. PlantCARE启动子在线分析软件预测含有光应答调控元件(Box I)、脱落酸应答元件(ABRE)、花粉发育应答元件(GGTT motif,GTGA motif)及细胞周期转换结合位点(E2F-binding site)等.为了分析其启动子活性, 通过替换pBI121载体上的CaMV35S启动子,构建了TaPCNA启动子与β-葡糖醛酸酶(GUS)基因的融合表达载体,通过农杆菌介导法在烟草叶片中进行瞬时表达. GUS组织化学染色结果表明,TaPCNA基因启动子能够驱动GUS基因在烟草叶片中表达,证实了所获得的启动子序列具有启动活性.本研究通过hiTAIL-PCR法克隆得到TaPCNA基因的启动子,为深入研究该基因的功能奠定了基础.  相似文献   

16.
PC10 is a monoclonal antibody to proliferating cell nuclear antigen, a nuclear protein associated with the cell cycle. We have evaluated the effects of tissue fixation on PC10 immunoreactivity in sections of paraffin embedded rat tissues. Immunoreactivity was well preserved in tissues after fixation with alcohol-based solutions for 3-24 hr. Fewer PC10-positive cells were detectable in samples fixed with formaldehydecontaining solutions compared with samples fixed with alcohol for the same time. Loss of PC10 immunoreactivity in formaldehyde fixed tissues was progressive, and quantifiable as early as after 3 hr fixation. Consequently, alcohol-based fixatives are strongly recommended for any immunocytochemical prospective study using PC10 antibody. In contrast, loss of PC10-immunoreactivity is always predictable, but difficult to quantitate, using formaldehyde fixed specimens. This aspect should be considered when using PC10 antibody in retrospective studies with routinely-processed archival material.  相似文献   

17.
本实验用免疫印迹法纯化的抗EBNA亚型抗体,结合显微荧光分光光度检测技术,检测在不同感染状态下,三种亚型EBNA抗原在细胞中的表达程度。结果表明,处于潜伏感染状态下的Raji细胞EBNA-1表达量较大,经巴豆油和正丁酸诱导进入钝挫感染状态后EBNA-1表达减少,而EBNA-2的表达增强。B_(95-8)细胞也有相似的趋势。表明EB病毒的激活可能与不同EBNA亚型表达量的改变有关。  相似文献   

18.
Ubiquitin conjugation provides a crucial signaling role in hundreds of cellular pathways; however, a structural understanding of ubiquitinated substrates is lacking. One important substrate is monoubiquitinated PCNA (PCNA-Ub), which signals for recruitment of damage-tolerant polymerases in the translesion synthesis (TLS) pathway of DNA damage avoidance. We use a novel and efficient enzymatic method to produce PCNA-Ub at high yield with a native isopeptide bond and study its Usp1/UAF1-dependent deconjugation. In solution we find that the ubiquitin moiety is flexible relative to the PCNA, with its hydrophobic patch mostly accessible for recruitment of TLS polymerases, which promotes the interaction with polymerase η. The studies are a prototype for the nature of the ubiquitin modification.  相似文献   

19.
Arterial injury-induced vascular smooth muscle cell (VSMC) proliferation in intima is the important etiologic factor in vascular proliferative disorders such as atherosclerosis, hypertension and restenosis after balloon angioplasty. Butyrate, a naturally occurring short chain fatty acid, is produced by bacterial fermentation of dietary fiber and by mammary glands of certain mammals. Studies have shown that butyrate at millimolar concentrations, which are physiological, induces growth arrest, differentiation and apoptosis. We examined the effect of physiological concentrations of butyrate on rat VSMC proliferation and proliferation-induced PCNA expression to determine anti-atherogenic potential of butyrate. Butyrate concentrations, closer to physiological range, exhibited antiproliferative effects on both serum-induced proliferation of serum-starved quiescent VSMCs and actively proliferating non-confluent VSMCs. Treatment of serum-starved quiescent VSMCs with 1-8 mmol/l concentration of butyrate caused a concentration-dependent decrease in serum-induced VSMC proliferation and cell proliferation-associated increase in total cellular proteins and RNA levels. Similarly, exposure of actively growing VSMCs to 5 mmol/l butyrate resulted in the inhibition of cell proliferation and proliferation-induced increase in cellular proteins and RNA levels. Furthermore, cellular morphology was significantly altered. Analysis of cell cycle regulatory proteins indicated that levels of PCNA, an excellent marker for cell proliferation, was significantly altered by butyrate both in actively proliferating and serum-induced quiescent VSMCs. These observations suggest that butyrate exhibits potential antiatherogenic capability by inhibiting VSMC proliferation and proliferation-associated increase in PCNA expression and thus merits further investigations regarding therapeutic significance of butyrate in vascular proliferative disorders.  相似文献   

20.
The growth of the Spodoptera frugiperda cell line Sf9 was studied in batch and continuous culture. The results of batch cultivations showed that glucose was the preferred energy and carbon source limiting the cell density in both TNM-FH and IPL-41 media. Continuous culture using IPL-41-based feeding medium with different glucose (2.5, 5 and 10 g l−1) and yeast extract concentrations (4, 8 and 16 g l−1) showed that in serum-supplemented medium the maximum cell density was limited by glucose and yeast extract concentration. The transition to glucose limitation caused a decrease in growth rate and viability. A high cell density culture (18 × 106 ml−1) was obtained using a glucose concentration of 10 g l−1 and a yeast extract concentration of 8 g l−1 in the feeding medium. A yeast extract concentration of 16 g l−1 inhibited growth. Unlike mammalian cell cultures, lactate, alanine and ammonia were not involved in growth inhibition. Lactate did not accumulate under aerobic conditions. Ammonia accumulation, if observed, was insignificant. The level of alanine synthesized and excreted into the culture medium never reached an inhibitory level. During glucose limitation alanine did not accumulate and ammonia was released. However, even in the presence of glucose significant amounts of Asp, Glu, Gln, Asn, Ser, Arg and Met were utilized for energy production. The amino groups of these amino acids were transferred to pyruvate or used for nucleic acid synthesis and excreted in the form of alanine into the culture medium. The consumption of His, Lys, Thr, Gly, Val, Leu, Phe, Tyr, Trp and Ile by growing Sf-9 cells was almost equal to their concentration in the biomass.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号